Lexeo Therapeutics, Inc. Common Stock (LXEO) institutional holders · rev $654.0K
Lexeo Therapeutics, Inc. Common Stock institutional holders from SEC Form 13F, top 4 by reported value. Each row is the filer's newest 13F for quarters ended 2026-03-31 or later, share lines summed, options excluded; value is the 13F-reported market value in US dollars. Rows marked Prior quarter are filers whose 2026-06-30 13F is not cached yet.
| Holder | Shares | Value | Report |
|---|---|---|---|
| CITADEL ADVISORS LLC | 3,834,999 | $22.0M | 2026-03-31Prior quarter |
| STATE STREET CORP | 4,354,757 | $20.3M | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | 1,949,885 | $11.2M | 2026-03-31Prior quarter |
| FMR LLC | 141,146 | $657.0K | 2026-06-30 |
LXEO institutional holders FAQ
How many LXEO 13F holders are listed on this page?
This page lists 2 cached Lexeo Therapeutics, Inc. Common Stock (LXEO) 13F holders. Holders: https://lician.com/institutional/lxeo
Who is the largest LXEO 13F holder by reported value?
The largest cached 13F holder by reported value on this page is STATE STREET CORP. Filer: https://lician.com/institutional/lxeo/93751. Holders: https://lician.com/institutional/lxeo
What value and shares did the largest LXEO 13F holder report?
STATE STREET CORP, the largest cached 13F holder by reported value on this page, reported 4,354,757 shares and a value of $20.3M.
What is the latest LXEO 13F report date on this page?
The latest cached 13F report date on this Lexeo Therapeutics, Inc. Common Stock (LXEO) holders table is Jun 30, 2026.
Which LXEO 13F holders report the largest positions?
The largest cached 13F holders by reported value on this Lexeo Therapeutics, Inc. Common Stock (LXEO) page are STATE STREET CORP and FMR LLC. Holders: https://lician.com/institutional/lxeo
Where are LXEO institutional holders listed?
Cached 13F holders for Lexeo Therapeutics, Inc. Common Stock (LXEO) are listed at https://lician.com/institutional/lxeo. Filer directory: https://lician.com/holders
What is LXEO's latest revenue?
Latest cached Lexeo Therapeutics, Inc. Common Stock (LXEO) revenue for Dec 31, 2022 was $654.0K. Statements: https://lician.com/financials/lxeo
Not investment advice. Figures as filed or reported, not a live feed.